Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Tenet is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-09-22Current report (material event)
- 8-K2026-09-08Current report (material event)
- SCHEDULE 13G/A2026-09-04SCHEDULE 13G/A
- SCHEDULE 13G/A2026-08-14SCHEDULE 13G/A
- SCHEDULE 13G/A2026-08-06SCHEDULE 13G/A
- 10-Q2026-07-29Quarterly report
- 8-K2026-07-23Current report (material event)
- 8-K2026-05-29Current report (material event)
- 10-Q2026-04-30Quarterly report
- SCHEDULE 13G2026-04-30SCHEDULE 13G
- 8-K2026-04-30Current report (material event)
- ARS2026-04-16Annual report to holders
- DEFA14A2026-04-16DEFA14A
- DEF 14A2026-04-16Proxy statement
- 8-K2026-04-10Current report (material event)
- 8-K2026-03-30Current report (material event)
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- 10-K2026-02-17Annual report
- 8-K2026-02-11Current report (material event)
- 8-K2026-02-02Current report (material event)
- 8-K2025-11-24Current report (material event)
- 8-K2025-11-18Current report (material event)
- 8-K2025-11-05Current report (material event)
- 8-K2025-11-03Current report (material event)
- 10-Q2025-10-28Quarterly report
- 8-K2025-10-28Current report (material event)
- 10-Q2025-07-30Quarterly report
- 8-K2025-07-22Current report (material event)
- 8-K2025-06-05Current report (material event)
- 8-K2025-05-27Current report (material event)
- SCHEDULE 13G/A2025-05-09SCHEDULE 13G/A
- 10-Q2025-04-29Quarterly report
- 8-K2025-04-29Current report (material event)
- PX14A6G2025-04-17PX14A6G
- SCHEDULE 13G/A2025-04-17SCHEDULE 13G/A
- ARS2025-04-11Annual report to holders
- DEFA14A2025-04-11DEFA14A
- DEF 14A2025-04-11Proxy statement
- 10-K2025-02-18Annual report
- 8-K2025-02-12Current report (material event)
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.